$RNGE
RANGE IMPACT, INC. Stock $rnge

$rnge Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224019870 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$2.350M	$3.910M	$6.878M
YoY Change	-41.23%	29.69%	159.95%
Cost Of Revenue	$2.499M	$3.428M	$4.995M
YoY Change	-20.76%	44.91%	198.16%
Gross Profit	-$148.9K	$481.5K	$1.883M
YoY Change	-117.62%	-25.8%	94.01%
Gross Profit Margin	-6.34%	12.32%	27.38%
Selling, General & Admin	$697.7K	$943.9K	$1.603M
YoY Change	9.72%	30.0%	83.03%
% of Gross Profit		196.01%	85.11%
Research & Development	$157.3K	$131.6K	$104.4K
YoY Change	46.38%	23.98%	-19.98%
% of Gross Profit		27.34%	5.55%
Depreciation & Amortization	$638.4K	$638.4K	$711.7K
YoY Change	86.83%	80.26%	242.8%
% of Gross Profit		132.58%	37.8%
Operating Expenses	$855.0K	$1.076M	$1.707M
YoY Change	15.02%	29.24%	69.67%
Operating Profit	-$1.004M	-$594.0K	$124.0K
YoY Change	-1086.55%	224.19%	-585.17%
Interest Expense	$165.7K	$175.3K	-$259.0K
YoY Change	154.87%	301.63%	902.24%
% of Operating Profit			-208.82%
Other Income/Expense, Net	-$165.2K	-$157.2K
YoY Change	154.13%	260.14%
Pretax Income	-$1.169M	-$751.2K	-$83.02K
YoY Change	-3280.3%	231.11%	35.21%
Income Tax	$56.60K
% Of Pretax Income
Net Earnings	-$1.226M	-$751.1K	-$83.02K
YoY Change	-3434.1%	231.11%	61.52%
Net Earnings / Revenue	-52.16%	-19.21%	-1.21%
Basic Earnings Per Share	-$0.01	-$0.01
Diluted Earnings Per Share	-$0.01	-$0.01
COMMON SHARES
Basic Shares Outstanding	101.0M shares	101.0M shares	89.69M shares
Diluted Shares Outstanding	101.6M shares	101.0M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$123.7K	$667.7K	$2.177M
YoY Change	-65.59%	191.55%	392.08%
Cash & Equivalents	$123.7K	$667.7K	$2.177M
Short-Term Investments
Other Short-Term Assets	$42.20K	$90.76K	$115.3K
YoY Change	-11.57%	10213.64%	13004.55%
Inventory	$725.4K
Prepaid Expenses	$42.20K	$90.76K	$115.3K
Receivables	$4.389M	$6.004M	$7.185M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.655M	$7.389M	$9.725M
YoY Change	136.84%	404.88%	582.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.03M	$12.66M	$13.30M
YoY Change	96.04%	96.71%	120.03%
Goodwill	$751.4K	$751.4K	$751.4K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$9.980K	$9.980K	$9.980K
YoY Change	-50.05%	12.26%	12.26%
Total Long-Term Assets	$12.79M	$13.42M	$14.06M
YoY Change	85.16%	86.51%	106.64%
TOTAL ASSETS
Total Short-Term Assets	$6.655M	$7.389M	$9.725M
Total Long-Term Assets	$12.79M	$13.42M	$14.06M
Total Assets	$19.44M	$20.81M	$23.79M
YoY Change	100.11%	140.3%	189.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.037M	$1.706M	$3.714M
YoY Change	163.54%	64.96%	1488.49%
Accrued Expenses	$54.40K	$71.67K	$101.3K
YoY Change
Deferred Revenue		$205.3K
YoY Change
Short-Term Debt	$2.200M	$2.400M	$2.400M
YoY Change	83.33%	2300.0%
Long-Term Debt Due	$2.617M	$2.514M	$2.756M
YoY Change	140.24%	145.16%	108.9%
Total Short-Term Liabilities	$7.059M	$6.897M	$8.971M
YoY Change	130.5%	219.35%	477.66%
LONG-TERM LIABILITIES
Long-Term Debt	$4.199M	$5.096M	$5.250M
YoY Change	21.43%	34.5%	40.45%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$4.199M	$5.096M	$5.250M
YoY Change	21.43%	34.5%	40.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.059M	$6.897M	$8.971M
Total Long-Term Liabilities	$4.199M	$5.096M	$5.250M
Total Liabilities	$11.26M	$11.99M	$14.22M
YoY Change	72.66%	101.61%	168.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$49.52M	-$47.83M	-$47.08M
YoY Change	-1.75%	-5.17%	-6.24%
Common Stock	$57.71M	$56.65M	$56.65M
YoY Change	7.66%	6.59%	6.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.184M	$8.820M	$9.567M
YoY Change
Total Liabilities & Shareholders Equity	$19.44M	$20.81M	$23.79M
YoY Change	100.11%	140.3%	189.03%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$1.226M	-$751.1K	-$83.02K
YoY Change	-3434.1%	231.11%	61.52%
Depreciation, Depletion And Amortization	$638.4K	$638.4K	$711.7K
YoY Change	86.83%	80.26%	242.8%
Cash From Operating Activities	-$550.5K	-$1.113M	-$636.1K
YoY Change	-48.75%	-264.7%	1704.99%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$16.28K
YoY Change	-100.0%	-100.0%	-99.64%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00		-$16.28K
YoY Change	-100.0%		-99.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$396.1K
YoY Change		-36.74%
Cash From Financing Activities	6.500K	-$396.1K	1.803M
YoY Change	-99.48%	177.12%	-53.66%
NET CHANGE
Cash From Operating Activities	-550.5K	-$1.113M	-636.1K
Cash From Investing Activities	0.000		-16.28K
Cash From Financing Activities	6.500K	-$396.1K	1.803M
Net Change In Cash	-544.0K	-$1.509M	1.151M
YoY Change	-516.72%	607.33%	-261.04%
FREE CASH FLOW
Cash From Operating Activities	-$550.5K	-$1.113M	-$636.1K
Capital Expenditures	$0.00	$0.00	$16.28K
Free Cash Flow	-$550.5K	-$1.113M	-$652.4K
YoY Change	-50.52%	1480.36%	-85.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset		usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2024Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2024Q1	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2024Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P6Y
CY2024Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2024Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments		usd
CY2023	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	RNGE	Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged		shares
CY2024Q1	RNGE	Share Based Compensation Arrangements By Share Based Payment Award Options Exchanged In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExchangedInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	7388656	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9724845	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12663467	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13301902	usd
CY2024Q1	us-gaap	Goodwill Goodwill	751421	usd
CY2023Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9976	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9976	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	13424864	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	14063299	usd
CY2024Q1	us-gaap	Assets Assets	20813520	usd
CY2023Q4	us-gaap	Assets Assets	23788144	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1706394	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3714014	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2400000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2400000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2513820	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2755792	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	205327	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	71670	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	101283	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6897211	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8971089	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5095940	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5250027	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5095940	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5250027	usd
CY2024Q1	us-gaap	Liabilities Liabilities	11993151	usd
CY2023Q4	us-gaap	Liabilities Liabilities	14221116	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101023485	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101023485	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	101023	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	101023	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	56552294	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	56547804	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47832948	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47081799	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	8820369	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9567028	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20813520	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23788144	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3909893	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3014887	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	3428348	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	2365885	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	481545	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	649002	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	943901	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	726048	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	131640	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	106177	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1075541	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	832225	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-593996	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-183223	usd
CY2024Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	18105	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	175258	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	43637	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-157153	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-43637	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-751149	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-226860	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101023485	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101023485	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78116814	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78116814	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9567028	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4490	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	8820369	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2939443	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2939443	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-226860	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2712583	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2712583	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-751149	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-226860	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4490	usd
CY2024Q1	us-gaap	Depreciation Depreciation	638435	usd
CY2023Q1	us-gaap	Depreciation Depreciation	354184	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1181634	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	252147	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	379115	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-24568	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2007621	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	800619	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	205327	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-29614	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1113045	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	675796	usd
CY2023Q1	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease	746226	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-746226	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	383202	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	396057	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	626123	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	100000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-396057	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-142921	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1509102	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-213351	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2176800	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	442369	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	667698	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	229018	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	89570	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	43637	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zJ5VocYNRfBk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_z3BswfsZWbfc">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3909893	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3014887	usd
CY2024Q1	us-gaap	Billed Contract Receivables BilledContractReceivables	504050	usd
CY2023Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	2100255	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6003777	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7185411	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	RNGE	Costs Incurred On Contracts In Progress CostsIncurredOnContractsInProgress	920618	usd
CY2023Q4	RNGE	Costs Incurred On Contracts In Progress CostsIncurredOnContractsInProgress	425634	usd
CY2024Q1	RNGE	Estimated Earnings EstimatedEarnings	716038	usd
CY2023Q4	RNGE	Estimated Earnings EstimatedEarnings	340528	usd
CY2024Q1	RNGE	Revenue Earned On Contracts In Progress RevenueEarnedOnContractsInProgress	1636656	usd
CY2023Q4	RNGE	Revenue Earned On Contracts In Progress RevenueEarnedOnContractsInProgress	766162	usd
CY2024Q1	RNGE	Contract Billings To Date ContractBillingsToDate	1215558	usd
CY2023Q4	RNGE	Contract Billings To Date ContractBillingsToDate	518852	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	421098	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	247310	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	626425	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	247310	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	205327	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	421098	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	247310	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2935759	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2297324	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12663467	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13301902	usd
CY2024Q1	us-gaap	Depreciation Depreciation	638435	usd
CY2023	us-gaap	Depreciation Depreciation	1781573	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14699212	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14705879	shares
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14699212	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14705879	shares
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	6	segment
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment	6156000	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand	554900	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	199500	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	6910400	usd
CY2024Q1	us-gaap	Goodwill Goodwill	751421	usd
CY2023Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2023Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2022Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2024Q1	us-gaap	Goodwill Goodwill	751421	usd
CY2023Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2024Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	4490	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	0	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	17960	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11392544	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.47
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	6667	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	4.70
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11385877	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.46
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11185877	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.47
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11385877	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1133480	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11385877	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11185877	shares
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2024-11-30
CY2022Q4	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.01	pure
CY2024Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0950	pure
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	1000000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	1000000	usd
CY2024Q1	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	mature between 2025 through 2029
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	6	segment
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	6	segment
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3909893	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	481545	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-751149	usd
CY2024Q1	us-gaap	Assets Assets	20813520	usd
CY2024Q1	us-gaap	Depreciation Depreciation	638435	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	175258	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3014887	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	649002	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-226860	usd
CY2023Q1	us-gaap	Assets Assets	8661303	usd
CY2023Q1	us-gaap	Depreciation Depreciation	354184	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	43637	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	746226	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-24-019870-index-headers.html	Edgar Link	pending
0001493152-24-019870-index.html	Edgar Link	pending
0001493152-24-019870.txt	Edgar Link	pending
0001493152-24-019870-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rnge-20240331.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
rnge-20240331_def.xml	Edgar Link	unprocessable
rnge-20240331_lab.xml	Edgar Link	unprocessable
rnge-20240331_pre.xml	Edgar Link	unprocessable
rnge-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RNGE
RANGE IMPACT, INC. Stock $rnge

2024 Q2 Form 10-Q Financial Statement

#000149315224019870 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNGE RANGE IMPACT, INC. Stock $rnge

2024 Q2 Form 10-Q Financial Statement

#000149315224019870 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNGE
RANGE IMPACT, INC. Stock $rnge